Two Sigma Investments’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-65,732
| Closed | -$107K | – | 3359 |
|
2024
Q4 | $107K | Buy |
65,732
+48,132
| +273% | +$78.5K | ﹤0.01% | 2900 |
|
2024
Q3 | $67.2K | Hold |
17,600
| – | – | ﹤0.01% | 2880 |
|
2024
Q2 | $51.6K | Buy |
+17,600
| New | +$51.6K | ﹤0.01% | 2803 |
|
2024
Q1 | – | Sell |
-40,576
| Closed | -$202K | – | 3197 |
|
2023
Q4 | $202K | Sell |
40,576
-87,019
| -68% | -$432K | ﹤0.01% | 2752 |
|
2023
Q3 | $644K | Sell |
127,595
-106,551
| -46% | -$538K | ﹤0.01% | 2094 |
|
2023
Q2 | $1.18M | Sell |
234,146
-354,904
| -60% | -$1.79M | ﹤0.01% | 1783 |
|
2023
Q1 | $3.62M | Buy |
589,050
+92,581
| +19% | +$569K | 0.01% | 1002 |
|
2022
Q4 | $6.55M | Buy |
496,469
+198,257
| +66% | +$2.62M | 0.02% | 700 |
|
2022
Q3 | $886K | Sell |
298,212
-143,299
| -32% | -$426K | ﹤0.01% | 1472 |
|
2022
Q2 | $1.61M | Buy |
441,511
+17,940
| +4% | +$65.5K | 0.01% | 1265 |
|
2022
Q1 | $2.62M | Sell |
423,571
-58,595
| -12% | -$363K | 0.01% | 1185 |
|
2021
Q4 | $3.91M | Buy |
482,166
+101,424
| +27% | +$822K | 0.01% | 999 |
|
2021
Q3 | $5.67M | Buy |
380,742
+311,635
| +451% | +$4.64M | 0.01% | 841 |
|
2021
Q2 | $867K | Buy |
+69,107
| New | +$867K | ﹤0.01% | 1747 |
|
2021
Q1 | – | Sell |
-11,290
| Closed | -$24K | – | 2623 |
|
2020
Q4 | $24K | Buy |
+11,290
| New | +$24K | ﹤0.01% | 1960 |
|
2019
Q1 | – | Sell |
-11,852
| Closed | -$76K | – | 2379 |
|
2018
Q4 | $76K | Sell |
11,852
-1,527
| -11% | -$9.79K | ﹤0.01% | 1978 |
|
2018
Q3 | $219K | Buy |
13,379
+7
| +0.1% | +$115 | ﹤0.01% | 1843 |
|
2018
Q2 | $275K | Buy |
13,372
+11,750
| +724% | +$242K | ﹤0.01% | 1812 |
|
2018
Q1 | $38K | Buy |
+1,622
| New | +$38K | ﹤0.01% | 1917 |
|